Quinolones Market 2026 progressing toward $66.44 billion by 2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Quinolones Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The quinolones market has experienced consistent expansion in recent years. Its valuation is projected to increase from $51.89 billion in 2025 to $54.48 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 5.0%. This historical growth can be attributed to factors such as the increasing prevalence of bacterial infections, a rise in hospital admissions, strong demand for broad-spectrum antibiotics, the expansion of retail pharmacies, and government initiatives aimed at controlling infectious diseases.

The quinolones market is projected to experience substantial expansion in the coming years, anticipated to reach $66.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.1%. This projected growth is driven by several factors, including progress in precision medicine, the creation of new quinolone formulations, the proliferation of online pharmacy platforms, heightened understanding of antimicrobial stewardship, and the increasing use of digital health monitoring instruments. Key developments expected during this timeframe encompass enhanced management of antibiotic resistance, a wider availability of generic drugs, individualized treatment strategies, an increase in outpatient and home healthcare provisions, and greater investment in research and development for new quinolones.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp

What Major Drivers Are Influencing Demand In The Quinolones Market?

The escalating threat of antimicrobial resistance is projected to drive the expansion of the quinolones market in the future. Antimicrobial resistance (AMR) denotes the capacity of microorganisms, including bacteria, viruses, parasites, and fungi, to withstand the influence of antimicrobial medications. With a wide spectrum of activity, quinolones prove effective against numerous bacteria. They are prescribed for particular infection types, possessing the capability to permeate diverse tissues and emerge as a favored alternative when options are restricted. As an illustration, a comprehensive global analysis detailed in October 2025 by the World Health Organization, a US-based intergovernmental organization, explored the prevalence and trends of antibiotic resistance. This study utilized data from over 23 million confirmed cases of bloodstream, urinary tract, and gastrointestinal infections, along with urogenital gonorrhea, with its conclusions drawn from reports submitted by 104 countries in 2023. Consequently, the growing threat of antimicrobial resistance is propelling the expansion of the quinolones market.

What Major Segment Divisions Exist Within The Quinolones Market?

The quinolones market covered in this report is segmented –

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types

2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

How Are Trends Shaping The Direction Of The Quinolones Market?

Key players in the quinolones market are prioritizing innovative offerings, such as fluoroquinolone antibiotic eye drops, to enhance their market revenues. These eye drops represent a category of antibiotics specifically designed to combat bacterial infections affecting the eye. For example, in July 2023, Harrow Health Inc., a US-based pharmaceutical entity, introduced Vigamox. This solution is isotonic, with an osmolality of about 290 mOsm/kg, and incorporates 5.45 mg moxifloxacin hydrochloride, which corresponds to 5 mg moxifloxacin base. The medication is supplied in a 3-milliliter bottle and delivered as a sterile ophthalmic solution within a dispensing system consisting of a tan polypropylene closure, a dispensing plug, and a natural low-density polyethylene bottle. Vigamox is advised for the prophylaxis of eye infections both preceding and following surgical interventions.

Which Companies Are Leading Innovation In The Quinolones Market?

Major companies operating in the quinolones market are Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

Read the full quinolones market report here:

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Quinolones Market?

North America was the largest region in the quinolones market in 2025. The regions covered in the quinolones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Quinolones Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9429&type=smp

Browse Through More Reports Similar to the Global Quinolones Market 2026, By The Business Research Company

Quinolones Market Report 2026

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

Quinoa Market Report 2026

https://www.thebusinessresearchcompany.com/report/quinoa-global-market-report

Fluoxetine Market Report 2026

https://www.thebusinessresearchcompany.com/report/fluoxetine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795